List of Excipients in API GRANISETRON
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GRANISETRON
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Kyowa Kirin Inc | SANCUSO | granisetron | 42747-726 | HIGH DENSITY POLYETHYLENE | 2025-01-22 |
| Kyowa Kirin Inc | SANCUSO | granisetron | 42747-726 | POLYESTER | 2025-01-22 |
| Kyowa Kirin Inc | SANCUSO | granisetron | 42747-726 | TITANIUM DIOXIDE | 2025-01-22 |
| Heron Therapeutics Inc | SUSTOL | granisetron | 47426-101 | METHOXY PEG-10 | 2024-09-28 |
| Cumberland Pharmaceuticals Inc | SANCUSO | granisetron | 66220-637 | HIGH DENSITY POLYETHYLENE | 2025-01-22 |
| Cumberland Pharmaceuticals Inc | SANCUSO | granisetron | 66220-637 | POLYESTER | 2025-01-22 |
| Cumberland Pharmaceuticals Inc | SANCUSO | granisetron | 66220-637 | TITANIUM DIOXIDE | 2025-01-22 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing GRANISETRON
Detailed excipient profiles for GRANISETRON
Excipient focus: ANHYDROUS CITRIC ACID
GRANISETRON drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | granisetron hydrochloride | 0143-9744 |
| Mylan Institutional LLC | granisetron hydrochloride | 67457-861 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZYL ALCOHOL
GRANISETRON drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | granisetron hydrochloride | 0143-9744 |
| Akorn | granisetron hydrochloride | 17478-546 |
| Yung Shin Pharmaceutical Inc Co Ltd | granisetron hydrochloride | 63126-332 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
GRANISETRON drug variants containing CELLULOSE, MICROCRYSTALLINE
GRANISETRON drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
GRANISETRON drug variants containing CITRIC ACID MONOHYDRATE
GRANISETRON drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: HIGH DENSITY POLYETHYLENE
GRANISETRON drug variants containing HIGH DENSITY POLYETHYLENE
| Company | Ingredient | NDC |
|---|---|---|
| Kyowa Kirin Inc | granisetron | 42747-726 |
| Cumberland Pharmaceuticals Inc | granisetron | 66220-637 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing HIGH DENSITY POLYETHYLENE
Excipient focus: HYDROCHLORIC ACID
GRANISETRON drug variants containing HYDROCHLORIC ACID
GRANISETRON drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
GRANISETRON drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
GRANISETRON drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | granisetron hydrochloride | 16714-221 |
| OrchidPharma Inc | granisetron hydrochloride | 42043-390 |
| Bionpharma Inc | granisetron hydrochloride | 69452-350 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
GRANISETRON drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | granisetron hydrochloride | 0054-0143 |
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
GRANISETRON drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | granisetron hydrochloride | 0054-0143 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
GRANISETRON drug variants containing LACTOSE MONOHYDRATE
GRANISETRON drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
GRANISETRON drug variants containing MAGNESIUM STEARATE
GRANISETRON drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHOXY PEG-10
GRANISETRON drug variants containing METHOXY PEG-10
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | granisetron | 47426-101 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing METHOXY PEG-10
Excipient focus: METHYLPARABEN
GRANISETRON drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AuroMedics Pharma LLC | granisetron hydrochloride | 55150-175 |
| WOCKHARDT LIMITED | granisetron hydrochloride | 55648-661 |
| Wockhardt USA LLC | granisetron hydrochloride | 64679-841 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing METHYLPARABEN
Excipient focus: PHENOL
GRANISETRON drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | granisetron hydrochloride | 63323-319 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing PHENOL
Excipient focus: POLYESTER
GRANISETRON drug variants containing POLYESTER
| Company | Ingredient | NDC |
|---|---|---|
| Kyowa Kirin Inc | granisetron | 42747-726 |
| Cumberland Pharmaceuticals Inc | granisetron | 66220-637 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing POLYESTER
Excipient focus: POLYETHYLENE GLYCOL
GRANISETRON drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 4000
GRANISETRON drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
GRANISETRON drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Breckenridge Pharmaceutical Inc | granisetron hydrochloride | 51991-735 |
| Natco Pharma Limited | granisetron hydrochloride | 63850-0005 |
| Ascend Laboratories LLC | granisetron hydrochloride | 67877-184 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLPARABEN
GRANISETRON drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AuroMedics Pharma LLC | granisetron hydrochloride | 55150-175 |
| WOCKHARDT LIMITED | granisetron hydrochloride | 55648-661 |
| Wockhardt USA LLC | granisetron hydrochloride | 64679-841 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
GRANISETRON drug variants containing SODIUM CHLORIDE
GRANISETRON drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
GRANISETRON drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | granisetron hydrochloride | 63323-319 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
GRANISETRON drug variants containing SODIUM HYDROXIDE
GRANISETRON drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
GRANISETRON drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
GRANISETRON drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TITANIUM DIOXIDE
GRANISETRON drug variants containing TITANIUM DIOXIDE
GRANISETRON drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
GRANISETRON drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | granisetron hydrochloride | 17478-546 |
| Akorn | granisetron hydrochloride | 17478-547 |
| >Company | >Ingredient | >NDC |
GRANISETRON drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
GRANISETRON drug variants containing WATER
GRANISETRON drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
